Status:
COMPLETED
Stress & Social Cognition in BPD (part 2)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Borderline Personality Disorder
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Pe...
Detailed Description
The investigators will examine whether MR stimulation enhances prosocial behavior in BPD patients under additional psychosocial stress. Participants will be randomly assigned to receive either fludroc...
Eligibility Criteria
Inclusion
- Inclusion Criteria "BPD group":
- clinical diagnosis of borderline personality disorder
- female
- BMI between 17.5-30
- Inclusion Criteria "control group":
- female
- BMI between 17.5-30
- no clinical diagnosis of any mental disorder
- Exclusion Criteria:
- acute depressive episode,
- acute or lifetime psychotic symptoms
- acute substance abuse
- physical illness
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05310253
Start Date
February 1 2022
End Date
March 1 2025
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite University
Berlin, Germany